glp 1/gip agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight The Sustained Effects of a
Description
Basically, glucagon-like peptide-1 (GLP-1) improves glycemic control in diabetic patients and improves heart and kidney health
Likewise, another study shows that Exenatide alleviates mitochondrial dysfunction and cognitive impairment in 5FAD mice (84)
Exercise training in the management of overweight and obesity in adults: Synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group
Concerns also exist about weight regain after discontinuing the medication
Clevel Clin J Med
